Cahill Represents Initial Purchasers in $2.50 Billion Notes Offerings for Bausch Health Companies Inc.
Date: 12/30/19
Cahill represented the initial purchasers in connection with concurrent Rule 144A offerings of $1,250,000,000 aggregate principal amount of 5.00% senior notes due 2028 and $1,250,000,000 aggregate principal amount of 5.250% senior notes due 2030 by Bausch Health Companies Inc., a multinational specialty pharmaceutical company. Proceeds from the offerings were used to finance amounts owed under a litigation settlement agreement, refinance existing indebtedness and pay related fees and expenses.